Coronary Artery Disease

Patients with peripheral artery disease and HF have higher rates of CAD and elevated risk for adverse CV events and mortality compared with patients with PAD but no HF, researchers reported.

Drinking more milk is associated with lower cholesterol levels and could reduce the risk for coronary artery disease, according to a study published in the International Journal of Obesity.

Biodegradable polymer sirolimus-eluting stent (Tivoli, Essen) vs. durable polymer SES (Firebird2, Microport) in patients with CAD.

Among patients with STEMI, prior transcatheter aortic valve replacement was associated with high rates of poor in-hospital and midterm clinical outcomes, according to a study published in the Journal of the American College of Cardiology.

In a cohort of real-world patients with stable ischemic heart disease who underwent PCI, only 14% could be classified similarly to patients from the ISCHEMIA trial, researchers reported.

Black patients with CAD aged 45 years or younger had more nontraditional risk factors than older Black patients with CAD, researchers reported at the virtual Society for Cardiovascular Angiography and Interventions Scientific Sessions.

For patients with a history of coronary artery disease or coronary stents who undergo total joint arthroplasty, use of topical and intravenous tranexamic acid is safe, according to published results.

Older men with higher bone mineral density and preserved cortical bone are less likely to experience a major adverse coronary event, according to a study published in the Journal of Bone and Mineral Research.

In a comparison of two erectile dysfunction medications in men with stable CAD, phosphodiesterase type 5, or PDE5, inhibitors were associated with better survival and outcomes compared with alprostadil, researchers reported.

Colchicine may be considered for the secondary prevention of CV events in chronic coronary disease; however, its long-term safety remains unknown, according to a review published in the European Heart Journal.